We monitor coming IPOs and cover ones of interest. Usually we like them to be more of a sure thing, but in some cases you can still learn a lot from a company's S-1 even if they don't end up going through with the IPO. Joe P.
We're happy to issue insights on demand for paying subscribers. Please raise such questions on our Discord server. That said, speculating about buyouts rarely goes well. Hasn't this company been spinning wheels for like three decades now? They surface when we cover gene editing stocks as a class, like here: www.nanalyze.com/2022/06/complete-list-gene-editing-stocks/
Want to hear about new exciting AI IPOs? Subscribe! ua-cam.com/users/nanalyze
Love that the latest happenings are always available on nana 🎉
Got to stay in front of the "news" before it becomes the "olds."
We monitor coming IPOs and cover ones of interest. Usually we like them to be more of a sure thing, but in some cases you can still learn a lot from a company's S-1 even if they don't end up going through with the IPO. Joe P.
Can you review Wisdomtree's etf QGRW? Whats the best growth etf for a core holding?
We may cover growth ETFs in the future - like this Sunday when we look at SPY vs QQQ. ;)
BLUE ? Your thoughts ? B/O possibly?
We're happy to issue insights on demand for paying subscribers. Please raise such questions on our Discord server. That said, speculating about buyouts rarely goes well. Hasn't this company been spinning wheels for like three decades now? They surface when we cover gene editing stocks as a class, like here: www.nanalyze.com/2022/06/complete-list-gene-editing-stocks/